Company: AEMD
Filing Date: 2025-02-12
Form Type: 10-Q
Source: 0001683168-25-000960
Chunk: 1

Company: AETHLON MEDICAL INC
Filing Date: 2025-02-12
Form: 10-Q
Item: Item 1
Chunk 1
---
,669 and 2,629,725 shares issued and outstanding as of December 31, 2024 and March 31, 2024, respectively 
     13,987  
     2,629 
  
    Additional paid-in capital 
     166,037,129  
     160,337,371 
  
    Accumulated other comprehensive loss 
     (17,026) 
     (6,940)
  
    Accumulated deficit 
     (161,699,924) 
     (154,566,728)

    Total stockholders’ equity 
     4,334,166  
     5,766,332 

    Total liabilities and stockholders’ equity 
    $6,525,359  
    $8,245,982 

The accompanying notes are an integral part
of these condensed consolidated financial statements.

 4 

AETHLON MEDICAL, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE LOSS

For the Three and Nine Month Periods Ended December
31, 2024 and 2023

(Unaudited)

    Three Months  Ended  December 31,  2024  
    Three Months  Ended  December 31,  2023  
    Nine Months  Ended  December 31,  2024  
    Nine Months  Ended  December 31,  2023 
  
    OPERATING EXPENSES 

    Professional fees 
    $377,877  
    $668,586  
    $1,563,995  
    $2,778,335 
  
    Payroll and related expenses 
     620,487  
     1,919,305  
     3,248,187  
     4,233,970 
  
    General and administrative 
     816,383  
     979,197  
     2,525,220  
     3,138,289 
  
    Total operating expenses 
     1,814,747  
     3,567,088  
     7,337,402  
     10,150,594 
  
    OPERATING LOSS 
     (1,814,747) 
     (3,567,088) 
     (7,337,402)